Riddhi Siddhi Gluco Biols Reports Strong Financial Performance in Q3 2024

Riddhi Siddhi Gluco Biols, a microcap trading company, has recently announced its financial results for the quarter ending September 2024. The company has seen a positive performance in this quarter, with a score of 10 out of 10, an improvement from 4 in the last 3 months.

According to the financials, Riddhi Siddhi Gl has shown significant growth in net sales, with a 169.72% increase year on year. The company's profit before tax (PBT) has also seen a substantial growth of 636.36% year on year. This trend is expected to continue in the near term, indicating a positive outlook for the company.

The company's operating profit to interest ratio has also improved, reaching its highest level in the last five quarters. This shows that Riddhi Siddhi Gl is effectively managing its interest payments, which is a positive sign for investors.

In terms of profitability, the company's profit after tax (PAT) has grown by 52.0% year on year, and its operating profit (PBDIT) has reached its highest level in the last five quarters. This indicates a positive trend in the company's profitability.

On the other hand, the company's interest cost has increased by 66.48% quarter on quarter, which could be a cause for concern as it signifies increased borrowings. Additionally, the company's non-operating income is 86.76% of its PBT, which is a high percentage and may not be a sustainable business model.

Overall, Riddhi Siddhi Gluco Biols has shown a positive financial performance in the quarter ending September 2024. However, investors should carefully consider the company's increasing interest cost and reliance on non-operating income before making any investment decisions.